Funding for this research was provided by:
National Institute on Aging (1R03AG061660-01, R21AG04388502)
Received: 6 November 2019
Accepted: 4 February 2020
First Online: 19 February 2020
Ethics approval and consent to participate
: This study was approved by Emory University’s institutional review board.
: Not applicable.
: WTH has a patent (assignee, Emory University) on the use of CSF p/t-Tau ratio in the evaluation of frontotemporal lobar degeneration, has received research support from Avid Pharmaceuticals, and has received travel support from Eli Lilly and Hoffman-La Roche. DQ has received research support from Medtronic and Siemens Healthcare.